Alvotech (ALVO)
5.53
-0.03
(-0.54%)
USD |
NASDAQ |
Dec 10, 16:00
5.59
+0.06
(+1.08%)
After-Hours: 20:00
Alvotech EPS Diluted (Quarterly): -0.0174 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.121 |
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Sofgen Pharma SA | -- |
| Amgen, Inc. | 5.934 |
| Voyager Therapeutics, Inc. | -0.4743 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.252M |
| Revenue (Quarterly) | 113.74M |
| Total Expenses (Quarterly) | 119.00M |
| Enterprise Value | 2.972B |
| Gross Profit Margin (Quarterly) | 69.22% |
| Profit Margin (Quarterly) | -4.62% |
| Earnings Yield | 4.16% |
| Operating Earnings Yield | 1.09% |
| Normalized Earnings Yield | 4.165 |